N
MDT icon

Natixis’s Medtronic MDT Stock Holding History

Natixis’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-463,759
Closed -$29.6M – 460
2014
Q2 		$29.6M Buy
463,759
+93,531
+25% +$5.68M 0.36% 71
2014
Q1 		$22.8M Buy
370,228
+353,225
+2,077% +$20.6M 0.3% 82
2013
Q4 		$976K Sell
17,003
-188,415
-92% -$10.7M 0.01% 353
2013
Q3 		$10.9M Buy
205,418
+199,806
+3,560% +$10.8M 0.12% 173
2013
Q2 		$289K Buy
+5,612
New +$277K ﹤0.01% 365

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Natixis's MDT Position: Q3 2014 in Review

Natixis sold out of Medtronic (MDT) in Q3 2014, closing a stake of 463,759 shares — an estimated $29.6M sold.

Natixis first reported a position in MDT in Q2 2013 and held it in 5 quarters. The position peaked at $29.6M in Q2 2014. 1,134 funds tracked by Wall St. Rank hold MDT as of Q3 2014.

  • Natixis reported no remaining Medtronic position as of Q3 2014 after selling out during the quarter.
  • Natixis sold 463,759 Medtronic shares in Q3 2014, an estimated $29.6M.
  • Natixis first reported a position in Medtronic in Q2 2013 and held it in 5 quarters.
  • Natixis's Medtronic position peaked at $29.6M in Q2 2014.
  • 1,134 funds tracked by Wall St. Rank held Medtronic as of Q3 2014.

Based on Natixis's 13F filing for Q3 2014, filed 14 Nov 2014.